Furthermore, we found that IO strongly activated AMPK compared with the addition of DFO, NAC or Catalase in MDS-MSCs, accompanied by an increase in LC3-II conversion and the protein level of Beclin-1, ATG5, ATG7 in three patients out of eight patients (Fig. 6f). This evidence concerns the gene BECN1 and myelodysplastic syndrome.